Dr. Nahoung Grace Lee, MD
Claim this profileStudies Graves Disease
1 reported clinical trial
2 drugs studied
Clinical Trials Nahoung Grace Lee, MD is currently running
More about Nahoung Grace Lee, MD
Clinical Trial Related5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Nahoung Grace Lee, MD has experience with
- Aflibercept
- Hyaluronidase
Breakdown of trials Nahoung Grace Lee, MD has run
Graves Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nahoung Grace Lee, MD specialize in?
Nahoung Grace Lee, MD focuses on Graves Disease and other conditions. In particular, much of their work with Graves Disease has involved treating patients, or patients who are undergoing treatment.
Is Nahoung Grace Lee, MD currently recruiting for clinical trials?
Yes, Nahoung Grace Lee, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Nahoung Grace Lee, MD has studied deeply?
Yes, Nahoung Grace Lee, MD has studied treatments such as Aflibercept, Hyaluronidase.
What is the best way to schedule an appointment with Nahoung Grace Lee, MD?
Apply for one of the trials that Nahoung Grace Lee, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.